What are your recommendations for a patient with metastatic non-mutated lung adenocarcinoma who previously had headaches responsive to prednisone but with negative temporal artery biopsy for GCA?  

For medical oncologists, would you offer a PD-1/L1 inhibitor? For other subspecialties, how would you counsel the oncologist regarding the risk of using a PD-1/L1 inhibitor?

Answer from: at Academic Institution
at Mayo Clinic College of Medicine
I agree with Dr. @Eli Miloslavsky. In this patient...
Sign in or Register to read more